N-acetylcysteine in the treatment of non-alcoholic steatohepatitis [5]

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 10, 2003, Pages 1220-1221

  Pamuk, Gülsüm Emel ^a   Sonsuz, Abdullah ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE;

ADULT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FATTY LIVER; FEMALE; HUMAN; LETTER; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0242487635     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03156.x     Document Type: Letter

References (5)

1. Teli MR, James OFW, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-19.
2. Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: Present and emerging therapies. Sem. Liver Dis. 2001; 21: 81-8.
3. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis leads to in vivo lipid peroxidation in mice. J. Hepatol. 1996; 24: 200-8.
4. Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J. Hepatol. 1997; 27: 363-70.
5. Gülbahar O, Karasu ZA, Ersöz G et al. Treatment non-alcoholic steatohepatitis with N-acetylcysteine (Abstract). Gastroenterology 2000; 118: A1444.